You are here:HomeFor CliniciansAbout the Meters
For Patients
What is PT/INR Self Testing?
How Self Testing Works
Benefits of Self Testing
Is Self Testing for You?
INR Meters
What People Say
Medications & Diet
Frequently Asked Questions
Get Started Now
For Clinicians
Improving Outcomes
How Self Testing Works
Which Patients Qualify
What Doctors Say
About the Meters
Frequently Asked Questions
Prescription - Rx
Clinician Info Kit
Published Research
Practical Implementation

About Us

About the PT/INR Meters

Improved outcomes for physicians, practitioners, and patients alike:

  • The latest technology in patient INR self-testing equipment
  • 24/7 local clinical support
  • Ongoing in-home education and training
  • Patient testing compliance managed on behalf of the practice
  • Ongoing testing strips and device supplies
  • Critical value physician alert parameters ensure no urgent INR value is overlooked Protection. For patients. For practices.


The Proof is in the Outcomes!

Studies show that patients are only in TTR 58% of the time during facility or clinic based management. RCS patients are within prescribed therapeutic range 77% of the time.



Dlott, Jeffrey S, et al. “A national assessment of warfarin anticoagulation for stroke prevention in atrial fibrillation.” Circulation. 2014 

Rose AJ, Hylek EM, et al. “Risk-adjusted percent time in therapeutic range as a quality indicator for outpatient oral anticoagulation:
Results of the veterans affairs study to improve anticoagulation (VARIA).” Circ Cardiovasc Qual Outcomes. 2011; 4:22-9 

Pokorney, Sean D. et al. “Patients’ time in therapuetic range on warfarin among US patients with atrial fibrillation:
Results from the ORBIT-AF registry.” American Heart Journal. 2015 

Lafata JE, Martin SA, Kaatz S, Ward RE. “Anticoagulation clinics and patient self-testing for patients on chronic warfarin therapy:
A cost-effectiveness analysis.”J Thromb Thrombolysis. 2000;9:S13–S19.

Henagen C et al. “Self-monitoring of oral anticoagulation: a systematic review and meta-analysis.” Lancet. 2006. 367:404-11

Internal INR value review of active patient tests Jan-Sept 2019.

COAG-SENSE® is a registered trademark of CoaguSense, Inc.

COAGUCHEK is a trademark of Roche